Colombia has one of the highest rates of access to hemophilia prophylaxis treatment in the world, with over 90% of those with severe hemophilia receiving prophylaxis. This is higher coverage than reported in other countries like the UK, Canada, Venezuela and Argentina. Prophylaxis treatment can significantly reduce bleeding and joint disease for those with hemophilia and improve quality of life.
1 of 6
Download to read offline
More Related Content
NIVEL PROFILAXIS HEMOFILIA en el mundo.pdf
1. Colombia,
is one of the countries with the
best access to
hemophilia prophylaxis
in the world.
Here’s the data
2. Worldwide,
only
30% of adults and
32% of children
with severe hemophilia
receive prophylaxis treatment.
Europe and the Americas stand out for having a
higher coverage, however, they do not reach 80% (1).
1. World Bleeding Disorders Registry 2022.
3. The results of
prophylaxis
with severe hemophilia are encouraging
compared to countries such as
Venezuela and Argentina, and are even
higher than the data reported in the
United Kingdom and Canada (1).
1. World Bleeding Disorders Registry 2022.
in colombian adults
4. Hemophilia prophylaxis
by age group
90%
40%
100%
97%
94%
82%
93%
99%
20%
30%
60%
70%
87%
90%
90%
96%
0% 20% 40% 60% 80% 100% 120%
Argentina
Venezuela
Peru
Chile
Canada
Brazil
United Kingdom
Colombia
>18 years old ≤18 years old
Country
Percentage of hemophilia prophylaxis
Source: World Federation of Hemophilia. 2022 Annual Survey Report.
5. •People with hemophilia who receive regular
prophylaxis have significantly fewer bleeds and a
reduction in joint disease.
•Prophylaxis can prevent or reduce the risk of
intracranial hemorrhage.
•Long-term benefits include reduced chronic pain,
reduced need for orthopedic surgeries,
hospitalizations, and emergency room visits.
•All of the above leads to a better quality of life and
greater participation (i.e. regular attendance) in
educational, recreational and professional activities.
Why is
hemophilia prophylaxis
Source: World Federation of Hemophilia.
important?